Related references
Note: Only part of the references are listed.Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics
Ling Song et al.
CLINICAL PHARMACOKINETICS (2018)
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
Dalong Zhu et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
A validated LC-MS/MS method of total and unbound lenvatinib quantification in human serum for protein binding studies by equilibrium dialysis
Yuji Mano et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples
Xiaohui (Sophia) Xu et al.
BIOANALYSIS (2014)
Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum
Brigitte Buscher et al.
BIOANALYSIS (2014)
The Clinical Relevance of Plasma Protein Binding Changes
Jason A. Roberts et al.
CLINICAL PHARMACOKINETICS (2013)
The bioanalytical challenge of determining unbound concentration and protein binding for drugs
Lars B. Nilsson
BIOANALYSIS (2013)
Impact of recovery on fraction unbound using equilibrium dialysis
Li Di et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Control and Measurement of Plasma pH in Equilibrium Dialysis: Influence on Drug Plasma Protein Binding
Ruth E. Curran et al.
DRUG METABOLISM AND DISPOSITION (2011)
Dalbavancin: Quantification in human plasma and urine by a new improved high performance liquid chromatography-tandem mass spectrometry method
Tanja Alebic-Kolbah et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry
Yuzhong Deng et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC-MS/MS
Henrik Sillen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Influence of Plasma Protein Binding on Pharmacodynamics: Estimation of In Vivo Receptor Affinities of β Blockers Using a New Mechanism-Based PK-PD Modelling Approach
T. J. Van Steeg et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Simultaneous determination of glipizide and rosiglitazone unbound drug concentrations in plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry
ZPJ Lin et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Share Paper
